...
首页> 外文期刊>Arthritis research & therapy. >Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression.
【24h】

Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression.

机译:类风湿性滑液产生白介素17的CD4T细胞具有丰富的肿瘤坏死因子-α共表达,但白介素22和白介素23R的表达很少。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Th17 cells have been implicated in the pathogenesis of rheumatoid arthritis (RA). The aim of this study was to systematically analyse the phenotype, cytokine profile and frequency of interleukin-17 (IL-17) producing CD4-positive T cells in mononuclear cells isolated from peripheral blood, synovial fluid and synovial tissue of RA patients with established disease, and to correlate cell frequencies with disease activity. METHODS: Flow cytometry was used to analyse the phenotype and cytokine production of mononuclear cells isolated from peripheral blood (PBMC) (n = 44), synovial fluid (SFMC) (n = 14) and synovium (SVMC) (n = 10) of RA patients and PBMC of healthy controls (n = 13). RESULTS: The frequency of IL-17-producing CD4 T cells was elevated in RA SFMC compared with RA PBMC (P = 0.04). However, the frequency of this population in RA SVMC was comparable to that in paired RA PBMC. The percentage of IL-17-producing CD4 T cells coexpressing tumor necrosis factor alpha (TNFalpha) was significantly increased in SFMC (P = 0.0068). The frequency of IFNgamma-producing CD4 T cells was also significantly higher in SFMC than paired PBMC (P = 0.042). The majority of IL-17-producing CD4 T cells coexpressed IFNgamma. IL-17-producing CD4 T cells in RA PBMC and SFMC exhibited very little IL-22 or IL-23R coexpression. CONCLUSIONS: These findings demonstrate a modest enrichment of IL-17-producing CD4 T cells in RA SFMC compared to PBMC. Th17 cells in SFMC produce more TNFalpha than their PBMC counterparts, but are not a significant source of IL-22 and do not express IL-23R. However, the percentage of CD4 T cells which produce IL-17 in the rheumatoid joint is low, suggesting that other cells may be alternative sources of IL-17 within the joints of RA patients.
机译:简介:Th17细胞与类风湿关节炎(RA)的发病机制有关。这项研究的目的是系统分析从患有疾病的RA患者的外周血,滑液和滑膜组织中分离出的单核细胞中产生白介素17(IL-17)的CD4阳性T细胞的表型,细胞因子谱和频率,并使细胞频率与疾病活动相关。方法:流式细胞术用于分析分离自外周血(PBMC)(n = 44),滑液(SFMC)(n = 14)和滑膜(SVMC)(n = 10)的单核细胞的表型和细胞因子产生。 RA患者和健康对照组的PBMC(n = 13)。结果:与RA PBMC相比,RA SFMC中产生IL-17的CD4 T细胞的频率升高(P = 0.04)。但是,该人群在RA SVMC中的发生频率与成对的RA PBMC中的发生频率相当。共表达肿瘤坏死因子α(TNFalpha)的产生IL-17的CD4 T细胞的百分比在SFMC中显着增加(P = 0.0068)。 SFMC中产生IFNγ的CD4 T细胞的频率也显着高于配对PBMC(P = 0.042)。大部分产生IL-17的CD4 T细胞共表达IFNγ。 RA PBMC和SFMC中产生IL-17的CD4 T细胞几乎没有IL-22或IL-23R共表达。结论:这些发现表明与PBMC相比,RA SFMC中产生IL-17的CD4 T细胞适度富集。 SFMC中的Th17细胞比PBMC中的Th17细胞产生更多的TNFα,但不是IL-22的重要来源,也不表达IL-23R。但是,在类风湿关节中产生IL-17的CD4 T细胞百分比很低,表明其他细胞可能是RA患者关节中IL-17的替代来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号